SavedAdd your journal

Journals / TSK Koruyucu Hekimlik Bülteni / 2011 / Cilt: 10 - Sayı: 2

The effect of the obesity on reproductive system

Obezitenin üreme sistemi üzerine etkisi

ÖZNUR KÖRÜKCÜ
Kamile KUKULU
Pages
231–238
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, we aim to discuss the impact of obesity on the various aspects of female reproductive function with focus on the clinical aspects of fertility problems in obese women.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Obesity may be described as the new worldwide epidemic, and its serious impact on morbidity and mortality are well known.
📊
Key Findings & Data:Obesity is the excessive accumulation of fat in the body, the result is a clinical condition.
💡
Conclusion & Impact:In this review, we aim to discuss the impact of obesity on the various aspects of female reproductive function with focus on the clinical aspects of fertility problems in obese women.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Obesity may be described as the new worldwide epidemic, and its serious impact on morbidity and mortality are well known. Obesity is the excessive accumulation of fat in the body, the result is a clinical condition. The reproductive problems associated with obesity encompasses a wide range of disorders including infertility problems, miscarriage and pregnancy complications. In this review, we aim to discuss the impact of obesity on the various aspects of female reproductive function with focus on the clinical aspects of fertility problems in obese women.

Özet

Obezite dünya çapında yaygın görülen, mortalite ve morbite üzerine ciddi etkileri olduğu bilinen bir durum olarak tanımlanabilir. Obezite vücutta yağ dokusunun aşırı birikmesi sonucu ortaya çıkan klinik bir durumdur. Obezite ile ilişkili üreme sorunları infertilite problemleri, düşüklere ve gebelik komplikasyonlarına kadar geniş bir yelpazeyi kapsamaktadır. Bu derleme ile obezitenin kadın üreme sistemindeki etkilerinin klinik yönlerine odaklanarak obez kadınlarda fertilite problemlerini tartışmayı hedefledik.

🔖

Cite This Article

KÖRÜKCÜ, Ö., KUKULU, K. (2011). The effect of the obesity on reproductive system. TSK Koruyucu Hekimlik Bülteni, Cilt: 10 - Sayı: 2, 231–238. https://ajindex.com/articles/150585

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. 1 Pasquali R, Pelusi C, Genghini S, Cacciari M, Gambineri A. Obesity and reproductive disorders in women. Hum Reprod Update. 2003; 9: 359-372. 2 Yılmaz C. Obezite. İstanbul. Nobel Tıp Kitabevleri Ltd, 1995, s. 95-105. 3 Kaltila-Heino R, Kosunen E, Rimpela M. Pubertal timing, sexual behavior and self-reported depression in middle adolescence. J Adolesc. 2003; 26: 531-545. 4 Lash MM, Armstrong A. Impact of obesity on women’s health. Fertil Steril. 2009; 91: 1712-1715. 5 Ahemed ML, Ong K, Morrel D, Cox L, Drayer N, Perry L. Longitudinal study of leptin concentrations during puberty: sex differences and relationship to changes in body composition. J Clin Endocrinol Metab. 1999; 84: 899–905. 6 Ahima RS, Dushay J, Flier SN, Prabakaran D, Flier JS. Leptin accelerates the onset of puberty in normal female mice. J Clin Invest. 1997; 99: 391-395. 7 Tang T, Glanville J, Hayden CJ, White D, Barth JH, Balen AH. Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study. Hum Reprod. 2006; 21: 80-89. 8 Essah PA, Apridonidze T, Iuorno MJ, Nestler JE. Effects of short-term and long-term metformin treatment on menstrual cyclicity in women with polycystic ovary syndrome. Fertil Steril. 2006; 86: 230-232. 9 Eisenhardt S, Schwarzmann N, Henschel V, et all. Early effects of metformin in women with polycystic ovary syndrome: a prospective randomized, double-blind, placebocontrolled trial. J Clin Endocrinol Metab. 2006; 91: 946-952. 10 The ESHRE Capri Work Group. Nutrition and reproduction in women. Hum Reprod Update. 2006; 12: 193-207. 11 Smallwood GH, Meador ML, Lenihan JP, Shangold GA, Fisher AC, Creasy GW, Efficacy and safety of a transdermal contraceptive system. Obstet Gynecol. 2001; 98: 799-805. 12 Koetsawang S, Ji G, Krishna U, Cuadros A, Dhall G, Wyss R. Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial: III. The relationship between pregnancy and body weight. Contraception. 1990; 41: 143-150. 13 Burkman R, Schlesselman JJ, Zieman M. Safety concerns and health benefits associated with oral contraception. Am J Obstet Gynecol. 2004; 190: 5-22. 14 Law G, Maclehose R.F, Longnecker M.P. Obesity and time to pregnancy. Hum Reprod. 2007; 22: 414-420. 15 Lord JM, Flight IH, Norman RJ. Insulin-sensitizing drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome. Cochrane Database Syst Rev. 2003; 3: